Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Fermenta Biotech Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹290.97Overvalued by 11.29%vs CMP ₹328.00

P/E (10.9) × ROE (24.9%) × BV (₹133.00) × DY (0.76%)

₹360.56Fairly Valued by 9.93%vs CMP ₹328.00
MoS: +9% (Thin)Confidence: 37/100 (Low)Models: 3 Under, 2 Fair, 3 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹411.0927%Under (+25.3%)
Graham NumberEarnings₹297.3716%Fair (-9.3%)
DCFCash Flow₹670.7613%Under (+104.5%)
Net Asset ValueAssets₹132.909%Over (-59.5%)
EV/EBITDAEnterprise₹434.3911%Under (+32.4%)
Earnings YieldEarnings₹295.509%Fair (-9.9%)
ROCE CapitalReturns₹207.449%Over (-36.8%)
Revenue MultipleRevenue₹159.077%Over (-51.5%)
Consensus (8 models)₹360.56100%Fairly Valued
Key Drivers: EPS CAGR 41.3% lifts DCF — verify sustainability. | Wide model spread (₹133–₹671) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 41.3%

*Investments are subject to market risks

Analyst Summary

Fermenta Biotech Ltd operates in the Pharmaceuticals segment, NSE: FERMENTA | BSE: 506414, current market price is ₹328.00, market cap is 965 Cr.. At a glance, stock P/E is 10.9, ROE is 24.9 %, ROCE is 23.0 %, book value is 133, dividend yield is 0.76 %. The latest intrinsic value estimate is ₹360.56, which is about 9.9% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹468 Cr versus the prior period change of 39.7%, while latest net profit is about ₹76 Cr with a prior-period change of 416.7%. The 52-week range shown on this page is 399/241, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisFermenta Biotech Ltd. is a Public Limited Listed company incorporated on 01/05/1951 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is…

This summary is generated from the stock page data available for Fermenta Biotech Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

73
Fermenta Biotech Ltd scores 73/100 (Strong)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health75/100 · Strong
ROCE 23.0% ExcellentROE 24.9% ExcellentD/E 0.57 ModerateInterest Coverage 0.0x RiskyProfitable 3/5 years Mixed
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 64.1% Stable
Earnings Quality65/100 · Strong
OPM expanding (11% → 17%) Improving
Quarterly Momentum80/100 · Strong
Revenue (4Q): +27% YoY AcceleratingProfit (4Q): +136% YoY StrongOPM: 18.0% (down 16.0% YoY) Margin pressure
Industry Rank85/100 · Strong
P/E 10.9 vs industry 53.8 Cheaper than peersROCE 23.0% vs industry 16.4% Above peersROE 24.9% vs industry 15.2% Above peers3Y sales CAGR: 6% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:35 am

Market Cap 965 Cr.
Current Price 328
Intrinsic Value₹360.56
High / Low 399/241
Stock P/E10.9
Book Value 133
Dividend Yield0.76 %
ROCE23.0 %
ROE24.9 %
Face Value 5.00
PEG Ratio0.26

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Fermenta Biotech Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Fermenta Biotech Ltd 965 Cr. 328 399/24110.9 1330.76 %23.0 %24.9 % 5.00
Fredun Pharmaceuticals Ltd 939 Cr. 1,716 1,999/63527.6 2940.04 %18.9 %15.8 % 10.0
Syncom Formulations (India) Ltd 1,050 Cr. 11.2 23.5/10.215.2 4.000.00 %18.6 %15.5 % 1.00
TTK Healthcare Ltd 1,107 Cr. 784 1,402/73515.9 7681.28 %9.26 %6.89 % 10.0
Wanbury Ltd 805 Cr. 230 330/16218.7 18.10.00 %36.7 %76.5 % 10.0
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Fermenta Biotech Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 55105825799977895156140136130137
Expenses 6586727174927776103103108104112
Operating Profit -101911-142551195337282725
OPM % -18%18%13%-24%25%6%1%20%34%26%21%20%18%
Other Income -19-82-6353324951
Interest 5654533443333
Depreciation 6666666666655
Profit before tax -41-12-29161-6124532282417
Tax % -8%373%0%0%38%885%0%6%16%-4%23%25%31%
Net Profit -38-52-2910-7-6113833221812
EPS in Rs -12.70-1.400.62-9.703.35-2.36-1.983.8712.5411.687.426.144.31

Last Updated: March 3, 2026, 9:54 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 5:10 am

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 139142155164302403292376397349335468544
Expenses 113126134152209248225293335330307352427
Operating Profit 26162112931566683621828115117
OPM % 19%11%13%7%31%39%23%22%16%5%8%25%21%
Other Income 3013961288-204719
Interest 54610142120191821171512
Depreciation 109810121215202628252422
Profit before tax 1437-676129435227-51-1083102
Tax % 24%67%61%49%28%8%-37%18%44%4%143%8%
Net Profit 1012-946117604315-53-247685
EPS in Rs 2.860.17-0.41-4.1412.2142.7120.2315.465.25-17.36-7.8426.1229.55
Dividend Payout % 29%249%-51%-5%2%1%24%16%23%-7%-16%9%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)-90.00%100.00%-550.00%611.11%154.35%-48.72%-28.33%-65.12%-453.33%54.72%416.67%
Change in YoY Net Profit Growth (%)0.00%190.00%-650.00%1161.11%-456.76%-203.07%20.38%-36.78%-388.22%508.05%361.95%

Fermenta Biotech Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:13%
5 Years:10%
3 Years:6%
TTM:59%
Compounded Profit Growth
10 Years:67%
5 Years:7%
3 Years:74%
TTM:532%
Stock Price CAGR
10 Years:21%
5 Years:-3%
3 Years:10%
1 Year:11%
Return on Equity
10 Years:12%
5 Years:6%
3 Years:4%
Last Year:25%

Last Updated: September 5, 2025, 3:30 pm

Balance Sheet

Last Updated: December 4, 2025, 2:52 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 22222514141414141515
Reserves 130129128142122246295346358301274348376
Borrowings 65718987173209224232239220139115112
Other Liabilities 616070758792809496102120137149
Total Liabilities 259262288307385551614687707637548614651
Fixed Assets 8785168172177178200263299267269227219
CWIP 3665654227157354521626
Investments 171815181080003000
Other Assets 1189499112193344342367373321277372406
Total Assets 259262288307385551614687707637548614651

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 141542599034634311610541
Cash from Investing Activity + -25-18-137-101-97-44-41-26-55-16-0
Cash from Financing Activity + 13110-128912-47-1-22-41-91-51
Net Cash Flow 2-21-4476-5721-419-1-10
Free Cash Flow -10-20-25-174255-3476768638
CFO/OP 62%119%35%35%83%79%73%92%85%610%370%38%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-39.00-55.00-68.00-75.00-80.00-53.00-158.00-149.00-177.00-202.00-111.000.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 10691101998359876680447674
Inventory Days 149125160208234347594441380309245306
Days Payable 12095113147183169260169154109182192
Cash Conversion Cycle 136122148160134237421338306244139189
Working Capital Days 9-61-49335443705467-18940
ROCE %9%3%6%2%31%41%12%13%7%-0%3%23%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 59.58%62.06%62.06%62.06%62.06%62.06%62.06%62.06%64.08%64.08%64.08%64.08%
FIIs 0.00%0.00%0.00%0.00%0.00%0.00%0.05%0.02%0.02%0.02%0.02%0.02%
Public 38.46%36.00%36.04%36.05%36.05%36.11%36.41%36.98%35.00%35.00%34.75%33.99%
Others 1.95%1.92%1.89%1.89%1.89%1.82%1.47%0.94%0.89%0.89%1.14%1.90%
No. of Shareholders 16,89716,14815,72115,15015,17814,58913,22112,92212,93012,84513,76014,139

Shareholding Pattern Chart

No. of Shareholders

Fermenta Biotech Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 26.35-7.99-17.855.3315.77
Diluted EPS (Rs.) 26.35-7.99-17.855.3315.69
Cash EPS (Rs.) 34.500.24-8.7714.0821.78
Book Value[Excl.RevalReserv]/Share (Rs.) 124.3398.76108.08128.76124.90
Book Value[Incl.RevalReserv]/Share (Rs.) 124.3398.76108.08128.76124.90
Revenue From Operations / Share (Rs.) 160.95116.25121.27138.15130.79
PBDIT / Share (Rs.) 41.6913.628.8824.1231.17
PBIT / Share (Rs.) 33.395.06-0.9015.2624.13
PBT / Share (Rs.) 28.53-3.42-17.989.3417.90
Net Profit / Share (Rs.) 26.19-8.31-18.565.2214.74
NP After MI And SOA / Share (Rs.) 26.35-7.99-17.855.3515.77
PBDIT Margin (%) 25.9011.717.3217.4623.83
PBIT Margin (%) 20.744.34-0.7411.0418.44
PBT Margin (%) 17.72-2.94-14.826.7613.68
Net Profit Margin (%) 16.27-7.15-15.303.7711.27
NP After MI And SOA Margin (%) 16.37-6.86-14.713.8712.06
Return on Networth / Equity (%) 21.19-7.98-16.364.1512.62
Return on Capital Employeed (%) 24.193.89-0.618.8114.56
Return On Assets (%) 12.50-4.20-8.092.186.62
Long Term Debt / Equity (X) 0.040.140.260.300.30
Total Debt / Equity (X) 0.300.450.680.630.57
Asset Turnover Ratio (%) 0.800.560.520.550.57
Current Ratio (X) 1.581.401.211.521.48
Quick Ratio (X) 0.990.890.580.740.70
Inventory Turnover Ratio (X) 4.450.700.770.911.06
Dividend Payout Ratio (NP) (%) 4.69-15.65-7.0046.680.00
Dividend Payout Ratio (CP) (%) 3.57217.49-15.5017.580.00
Earning Retention Ratio (%) 95.31115.65107.0053.320.00
Cash Earning Retention Ratio (%) 96.43-117.49115.5082.420.00
Interest Coverage Ratio (X) 8.572.311.234.075.00
Interest Coverage Ratio (Post Tax) (X) 6.380.02-0.201.883.37
Enterprise Value (Cr.) 831.46505.89464.45795.24883.96
EV / Net Operating Revenue (X) 1.771.511.332.002.34
EV / EBITDA (X) 6.8412.8718.1211.439.83
MarketCap / Net Operating Revenue (X) 1.701.300.881.491.91
Retention Ratios (%) 95.30115.65107.0053.310.00
Price / BV (X) 2.201.510.981.592.00
Price / Net Operating Revenue (X) 1.701.300.881.491.91
EarningsYield 0.09-0.05-0.160.020.06

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Fermenta Biotech Ltd. is a Public Limited Listed company incorporated on 01/05/1951 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1951PLC008485 and registration number is 008485. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 430.53 Cr. and Equity Capital is Rs. 14.58 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
PharmaceuticalsA-1501, Thane One, DIL Complex, Thane Maharashtra 400610Contact not found
Management
NamePosition Held
Mr. Pradeep M ChandanChairman & Ind.Dire (Non-Exe)
Mr. Krishna DatlaExe.Vice Chairman & Whole Time Director
Mr. Prashant NagreManaging Director
Mr. Satish VarmaExecutive Director
Ms. Anupama Datla DesaiExecutive Director
Ms. Rajeshwari DatlaNon Executive Director
Mr. Pramod KasatInd. Non-Executive Director
Ms. Rajashri OjhaInd. Non-Executive Director
Mr. Ramanand MundkurIndependent Director

FAQ

What is the intrinsic value of Fermenta Biotech Ltd and is it undervalued?

As of 24 April 2026, Fermenta Biotech Ltd's intrinsic value is ₹360.56, which is 9.93% higher than the current market price of ₹328.00, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (24.9 %), book value (₹133), dividend yield (0.76 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Fermenta Biotech Ltd?

Fermenta Biotech Ltd is trading at ₹328.00 as of 24 April 2026, with a FY2026-2027 high of ₹399 and low of ₹241. The stock is currently in the middle of its 52-week range. Market cap stands at ₹965 Cr..

How does Fermenta Biotech Ltd's P/E ratio compare to its industry?

Fermenta Biotech Ltd has a P/E ratio of 10.9, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Fermenta Biotech Ltd financially healthy?

Key indicators for Fermenta Biotech Ltd: ROCE of 23.0 % indicates efficient capital utilization; ROE of 24.9 % shows strong shareholder returns. Dividend yield is 0.76 %.

Is Fermenta Biotech Ltd profitable and how is the profit trend?

Fermenta Biotech Ltd reported a net profit of ₹76 Cr in Mar 2025 on revenue of ₹468 Cr. Compared to ₹15 Cr in Mar 2022, the net profit shows an improving trend.

Does Fermenta Biotech Ltd pay dividends?

Fermenta Biotech Ltd has a dividend yield of 0.76 % at the current price of ₹328.00. The company pays dividends, though the yield is modest.

Last Updated: April 2, 2026, 4:35 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 506414 | NSE: FERMENTA
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Fermenta Biotech Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports